 |
Also known as: Adcetris
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Brentuximab.
No reviews have yet been submitted. Be the first to review this drug.
May 18, 2012 - Biovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: ABPI), today announced...
MorphoSys to Present MOR208 Preclinical Combination Therapy Data at ASCO Meeting Synergistic Effects Seen with Four Approved Treatment Options Including...
A new targeted drug therapy may help treat certain advanced cancers in children, a new preliminary study indicates. In some cases, the oral medication even...
Looking for answers? Ask a question or go join the brentuximab support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Apr 16th, 2012), Cerner Multum™ (updated May 18th, 2012), Wolters Kluwer™ (updated Apr 29th, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
